Bumrungrad International Hospital
| タイ | トルコ | オーストリア | |
| 肺がんに対するターゲット療法 | - | から $5,000 / 170,000฿ | - |
Bookimedは肺がんに対するターゲット療法価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。到着時にクリニックで肺がんに対するターゲット療法代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。肺がんに対するターゲット療法で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。肺がんに対するターゲット療法の旅路でお一人になることはありません。
Targeted therapy for lung cancer is generally safer than chemotherapy because it specifically attacks cancer cells while sparing healthy tissue. Most patients manage side effects well under supervision at Joint Commission International (JCI) accredited facilities like Bumrungrad International Hospital in Bangkok, which serves 1,000,000 patients annually.
Bookimed Expert Insight: Data from top-tier Thai oncology departments shows that comprehensive genetic testing is the most critical safety step. Clinics like Bumrungrad International Hospital utilize advanced digital imaging and AI to monitor drug resistance, which typically occurs after 10-14 months. Knowing the next treatment sequence beforehand significantly improves the patient experience.
Patient Consensus: Many patients find the side effects like skin reactions manageable but emphasize that brain fog and fatigue are often underestimated. Most agree that having a clear plan for drug switches is essential for peace of mind.
To ensure high-quality target therapy for lung cancer in Thailand, prioritize oncologists with Thai Board of Medical Oncology certification and international fellowships. Look for specialists at JCI-accredited facilities like Bumrungrad International Hospital who demonstrate expertise in genomic profiling and NGS testing for specific mutations like EGFR, ALK, or ROS1.
Bookimed Expert Insight: Many patients overlook that top Thai oncologists at Bumrungrad International Hospital often hold dual certifications. With over 50% of their 1 million annual patients coming from abroad, these specialists are uniquely adapted to international protocols. When selecting a doctor, specifically ask for their PubMed publication count regarding targeted therapies to verify their clinical authority.
Patient Consensus: Patients emphasize the importance of choosing communicative specialists who prioritize precision medicine. They often recommend verifying NGS testing capabilities early to ensure the treatment plan aligns with the latest NCCN guidelines.
Comprehensive lung cancer targeted therapy packages in Thailand include advanced biomarker testing for mutations like EGFR or ALK and personalized drug protocols. These programs bundle oncology consultations, diagnostic imaging, and pharmacy services to precisely attack cancer cells while minimizing damage to healthy tissue.
Bookimed Expert Insight: Data from top-tier centers like Bumrungrad International Hospital shows a significant focus on international coordination. While basic packages cover initial drug cycles, patients should confirm if newer generation agents are stocked. Some advanced therapies cost 200,000 to 400,000 THB monthly and may require separate billing. Always verify if the package price includes these specific high-cost medications before starting.
Patient Consensus: Patients emphasize requesting an itemized list of included drugs to avoid unexpected costs. Many noted that genetic testing can add 2 to 4 weeks to the timeline.
Patients typically stay in Thailand for 14 to 21 days during the initial phase. This timeframe allows for essential genetic marker testing, specialist consultations at JCI-accredited facilities like Bumrungrad International Hospital, and monitoring after the first treatment cycle to manage any immediate side effects safely.
Bookimed Expert Insight: Data from Bumrungrad International Hospital shows that 50% of their 1 million annual patients are international. Because they use advanced digital imaging and EHRs, patients can often coordinate biopsy results remotely. This often reduces the first physical trip from 3 weeks down to 10 days.
Patient Consensus: Many patients recommend planning a minimum 2-week first trip for testing and setup. They emphasize confirming if your specific therapy is oral or IV before booking travel to avoid stay extensions.
Thailand is an ideal destination for lung cancer targeted therapy due to its JCI-accredited oncology centers and internationally trained specialists. Facilities like Bumrungrad International Hospital combine advanced molecular testing with significant cost advantages. Patients access cutting-edge drug protocols and personalized precision medicine within high-tech, patient-centric environments.
Bookimed Expert Insight: While Thailand offers world-class care, data suggests using it as a cost-effective treatment hub rather than a primary diagnostic center. You should secure your mutation testing at home first to ensure the Thai protocol matches your specific cancer profile. This cross-verification prevents delays once you arrive in Bangkok.
Patient Consensus: Patients value the significant savings on expensive medications but warn about the difficulty of transferring medical records back home. It is essential to secure all English-language treatment plans and imaging results before your departure to ensure seamless follow-up care.
Targeted therapy for lung cancer in Thailand is predominantly an outpatient procedure. Patients typically receive oral medications to take at home or undergo intravenous infusions in specialized oncology clinics. Hospitalization is rarely required unless initial doses need intensive monitoring for potential allergic reactions or complex combination treatments.
Bookimed Expert Insight: Data from major Bangkok centers shows a shift toward home-based care for EGFR-mutant lung cancer. While surgery may cost between $18,000 and $32,000, targeted therapy avoids high room charges. Many international patients successfully manage their entire treatment cycle from a nearby hotel rather than a hospital bed.
Patient Consensus: Patients value the convenience of `day procedures` where they receive infusions and return to their hotel immediately. It is frequently recommended to arrange a driver for the first visit in case of post-infusion fatigue.